Literature DB >> 1939569

Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay.

B L Lohman1, J Higgins, M L Marthas, P A Marx, N C Pedersen.   

Abstract

Assays that use rhesus macaque whole blood and an antigen capture enzyme-linked immunosorbent assay for the simian immunodeficiency virus (SIV) p27 core protein were developed for the isolation of SIV from the blood of infected animals, the titration of infectivity of SIV inocula, and the quantitation of virus neutralizing antibodies in serum. These assays required small amounts of whole blood, were adaptable to a microtiter format, and used substrates mainly of rhesus macaque origin.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1939569      PMCID： PMC270295          DOI： 10.1128/jcm.29.10.2187-2192.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus.

Authors:  M D Daniel; N L Letvin; P K Sehgal; G Hunsmann; D K Schmidt; N W King; R C Desrosiers
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

2.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Authors:  H Kestler; T Kodama; D Ringler; M Marthas; N Pedersen; A Lackner; D Regier; P Sehgal; M Daniel; N King
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

3.  Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals.

Authors:  S Sutjipto; N C Pedersen; C J Miller; M B Gardner; C V Hanson; A Gettie; M Jennings; J Higgins; P A Marx
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.

Authors:  J A McKeating; A McKnight; K McIntosh; P R Clapham; C Mulder; R A Weiss
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

5.  Quantitation of HIV-1 activity in tissue culture supernatants: effects of culture condition on syncytial assays and virus production.

Authors:  G Spickett; R E Beattie; L Bountiff; A G Dalgleish; A D Webster
Journal:  J Virol Methods       Date:  1989 Apr-May       Impact factor: 2.014

Review 6.  AIDS vaccines: concepts and first trials.

Authors:  P Sonigo; L Montagnier; P Tiollais; M Girard
Journal:  Immunodefic Rev       Date:  1989

7.  Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes.

Authors:  M Kannagi; L V Chalifoux; C I Lord; N L Letvin
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

8.  Humoral response to SIV/SMM infection in macaque and mangabey monkeys.

Authors:  P N Fultz; R B Stricker; H M McClure; D C Anderson; W M Switzer; C Horaist
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

9.  Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.

Authors:  S Lederman; R Gulick; L Chess
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

10.  Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM).

Authors:  P N Fultz; H M McClure; D C Anderson; W M Switzer
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205
View more
  32 in total

1.  Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

Authors:  C J Miller; M B McChesney; X Lü; P J Dailey; C Chutkowski; D Lu; P Brosio; B Roberts; Y Lu
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

Authors:  X Lü; H Kiyono; D Lu; S Kawabata; J Torten; S Srinivasan; P J Dailey; J R McGhee; T Lehner; C J Miller
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

3.  Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques.

Authors:  Y Lu; P Brosio; M Lafaile; J Li; R G Collman; J Sodroski; C J Miller
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

Authors:  K K Van Rompay; M D Miller; M L Marthas; N A Margot; P J Dailey; D R Canfield; R P Tarara; J M Cherrington; N L Aguirre; N Bischofberger; N C Pedersen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.

Authors:  L D Giavedoni; M C Velasquillo; L M Parodi; G B Hubbard; V L Hodara
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Expression of CD154 by a simian immunodeficiency virus vector induces only transitory changes in rhesus macaques.

Authors:  Vida L Hodara; M Cristina Velasquillo; Laura M Parodi; Luis D Giavedoni
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.

Authors:  Michael J Hofman; Joanne Higgins; Timothy B Matthews; Niels C Pedersen; Chalet Tan; Raymond F Schinazi; Thomas W North
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac.

Authors:  B Banapour; M L Marthas; R A Ramos; B L Lohman; R E Unger; M B Gardner; N C Pedersen; P A Luciw
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.

Authors:  K K Van Rompay; M G Otsyula; M L Marthas; C J Miller; M B McChesney; N C Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.

Authors:  C J Miller; M Marthas; J Torten; N J Alexander; J P Moore; G F Doncel; A G Hendrickx
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.